Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 2
1963 2
1964 3
1965 4
1966 5
1967 3
1968 6
1969 2
1971 3
1972 3
1973 2
1974 6
1976 5
1977 2
1978 8
1979 2
1980 3
1981 4
1982 7
1983 3
1984 3
1985 11
1986 2
1987 7
1988 6
1989 5
1990 10
1991 6
1992 10
1993 4
1994 7
1995 5
1996 9
1997 3
1998 6
1999 7
2000 4
2001 8
2002 9
2003 5
2004 6
2005 6
2006 3
2007 4
2008 1
2009 1
2010 1
2011 2
2012 1
2013 1
2019 2
2020 2
2021 2
2022 2
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Results by year

Filters applied: . Clear all
Page 1
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study.
Passaro A, Wang J, Wang Y, Lee SH, Melosky B, Shih JY, Wang J, Azuma K, Juan-Vidal O, Cobo M, Felip E, Girard N, Cortot AB, Califano R, Cappuzzo F, Owen S, Popat S, Tan JL, Salinas J, Tomasini P, Gentzler RD, William WN Jr, Reckamp KL, Takahashi T, Ganguly S, Kowalski DM, Bearz A, MacKean M, Barala P, Bourla AB, Girvin A, Greger J, Millington D, Withelder M, Xie J, Sun T, Shah S, Diorio B, Knoblauch RE, Bauml JM, Campelo RG, Cho BC; MARIPOSA-2 Investigators. Passaro A, et al. Among authors: greger j. Ann Oncol. 2024 Jan;35(1):77-90. doi: 10.1016/j.annonc.2023.10.117. Epub 2023 Oct 23. Ann Oncol. 2024. PMID: 37879444 Free article. Clinical Trial.
Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer.
Lim EA, Schweizer MT, Chi KN, Aggarwal R, Agarwal N, Gulley J, Attiyeh E, Greger J, Wu S, Jaiprasart P, Loffredo J, Bandyopadhyay N, Xie H, Hansen AR. Lim EA, et al. Among authors: greger j. Clin Genitourin Cancer. 2023 Jun;21(3):366-375. doi: 10.1016/j.clgc.2023.02.010. Epub 2023 Feb 28. Clin Genitourin Cancer. 2023. PMID: 36948922 Clinical Trial.
Aluminum metabolism.
Greger JL. Greger JL. Annu Rev Nutr. 1993;13:43-63. doi: 10.1146/annurev.nu.13.070193.000355. Annu Rev Nutr. 1993. PMID: 8369153 Review. No abstract available.
Aluminum exposure and metabolism.
Greger JL, Sutherland JE. Greger JL, et al. Crit Rev Clin Lab Sci. 1997;34(5):439-74. doi: 10.3109/10408369709006422. Crit Rev Clin Lab Sci. 1997. PMID: 9405895 Review.
Signaling by estrogens.
Cheskis BJ, Greger JG, Nagpal S, Freedman LP. Cheskis BJ, et al. Among authors: greger jg. J Cell Physiol. 2007 Dec;213(3):610-7. doi: 10.1002/jcp.21253. J Cell Physiol. 2007. PMID: 17886255 Review.
Aluminum and tin.
Greger JL. Greger JL. World Rev Nutr Diet. 1987;54:255-85. doi: 10.1159/000415308. World Rev Nutr Diet. 1987. PMID: 3327244 Review. No abstract available.
Dietary and other sources of aluminium intake.
Greger JL. Greger JL. Ciba Found Symp. 1992;169:26-35; discussion 35-49. doi: 10.1002/9780470514306.ch3. Ciba Found Symp. 1992. PMID: 1490425 Review.
236 results